Professor Eileen Kane holds a Ph.D. in molecular biology from Cornell University, where she received a research fellowship and the Vincent du Vigneaud Award for Excellence in Research. She published scientific papers in the Proceedings of the National Academy of Sciences and the Journal of Virology and conducted research at Memorial Sloan-Kettering Cancer Center in New York City. Her interest in the intersection of science and the law led her to obtain a J.D. and work as a scientific advisor and patent attorney in a major New York City law firm.

Professor Kane continues to draw upon her scientific and legal backgrounds, teaching a range of courses that blend the latest scientific advancements and fast-paced legal developments in biotechnology, the Internet, patent law, and evidence. Her scholarship is focused on biotechnology, including such issues as gene patenting and DNA evidence. Professor Kane is registered before the United States Patent and Trademark Office. She also maintains a website, KaneBioLaw, that covers legal and policy developments in biotechnology and genetics.

 

 Amicus Brief, “Association for Molecular Pathology v. Myriad Genetics” (Supreme Court, 2013).

Amicus Brief, “Association for Molecular Pathology v. United States Patent & Trademark Office” (Federal Circuit, 2012).

“Patenting Genes and Genetic Methods: What's At Stake?” 6 J. Bus. and Tech. L. 1 (2011).

Amicus Brief, “Association for Molecular Pathology v. United States Patent & Trademark Office” (Federal Circuit 2010).

“Protecting the Intellectual Foundations of Genetic Science,” 23 GeneWatch 16 (2010).

“Achieving Clinical Equality in an Influenza Pandemic: Patent Realities,” 39 Seton Hall L. Rev. 1137 (2009).

“Patent-Mediated Standards in Genetic Testing,” 2008 Utah L. Rev. 835 (2008).

“Molecules and Conflict: Cancer, Patents and Women's Health,” 15 Am. U. J. Gender Soc. Pol’y & L. 305 (2007).